Efficacy of baricitinib on chronic pericardial effusion in a patient with Aicardi-Goutieres syndrome
Por:
Casas-Alba D, Darling A, Caballero E, Mensa-Vilaró A, Bartrons J, Anton-Lopez J, Garcia-Cazorla A, Vanderver A and Armangue-Salvador T
Publicada:
11 abr 2022
Ahead of Print:
1 dic 2021
Resumen:
Filiaciones:
Casas-Alba D:
Pediatric Neurology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain
Darling A:
Pediatric Neurology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain
Caballero E:
Neuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain
Mensa-Vilaró A:
Immunology Department, Hospital Clínic, Barcelona, Spain
Bartrons J:
Cardiology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain
Anton-Lopez J:
Pediatric Rheumatology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain
Garcia-Cazorla A:
Inborn Errors of Metabolism Unit, Neurology Department, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain
Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
Vanderver A:
Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
Armangue-Salvador T:
Neuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain
Pediatric Neuroimmunology Unit, Neurology Department, Sant Joan de Déu Children's Hospital, University of Barcelona, Barcelona, Spain
Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain
Green Submitted
|